Artificial intelligence in multi-objective drug design |
| |
Affiliation: | 1. Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, Leiden, 2333 CC, the Netherlands;2. Leiden Institute of Advanced Computer Science, Leiden University, Niels Bohrweg 1, Leiden, 2333 CC, the Netherlands |
| |
Abstract: | The factors determining a drug's success are manifold, making de novo drug design an inherently multi-objective optimisation (MOO) problem. With the advent of machine learning and optimisation methods, the field of multi-objective compound design has seen a rapid increase in developments and applications. Population-based metaheuris-tics and deep reinforcement learning are the most commonly used artificial intelligence methods in the field, but recently conditional learning methods are gaining popularity. The former approaches are coupled with a MOO strat-egy which is most commonly an aggregation function, but Pareto-based strategies are widespread too. Besides these and conditional learning, various innovative approaches to tackle MOO in drug design have been proposed. Here we provide a brief overview of the field and the latest innovations. |
| |
Keywords: | Multi-objective optimisation Pareto dominance Compound optimisation |
本文献已被 ScienceDirect 等数据库收录! |
|